TL;DR: The Centers for Medicare & Medicaid Services modified NCD 225 governing Medicare coverage of pneumatic compression devices, effective March 7, 2026. Here's what billing teams need to know before claims hit the queue.
CMS updated its National Coverage Determination 225—the policy governing pneumatic compression devices (PCDs) for home use—with a modification effective 2026-03-07. This policy covers inflatable garments and electric pumps used to treat lymphedema and chronic venous insufficiency (CVI) with venous stasis ulcers. The real policy document references HCPCS code E0652 specifically for segmented, calibrated gradient pneumatic compression devices, though the full code list is not published with this version. If your DME billing team handles any PCD claims billed to Medicare, this policy governs your reimbursement eligibility and medical necessity documentation requirements.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Pneumatic Compression Devices |
| Policy Code | NCD 225 |
| Change Type | Modified |
| Effective Date | 2026-03-07 |
| Impact Level | High |
| Specialties Affected | DME suppliers, wound care, vascular surgery, lymphedema therapy, home health |
| Key Action | Audit your medical necessity documentation for all active PCD orders—lymphedema and CVI cases both have distinct conservative therapy trial requirements that must be documented before Medicare will cover the device |
CMS Pneumatic Compression Device Coverage Criteria and Medical Necessity Requirements 2026
NCD 225 is the National Coverage Determination governing Medicare coverage of pneumatic compression devices under the Durable Medical Equipment benefit category. The coverage policy is narrow and conditional—Medicare does not cover PCDs as a first-line intervention. Two clinical indications qualify, and each has its own documentation ladder your billing team needs to understand cold.
Lymphedema: Medicare covers PCDs in the home setting for lymphedema patients only after a four-week trial of conservative therapy. That trial must include all three elements: an appropriate compression bandage system or compression garment, exercise, and limb elevation. The treating physician must determine that the trial produced no significant improvement, or that significant symptoms remain despite completion. Missing any leg of that three-part trial in your documentation is a direct path to claim denial.
Chronic Venous Insufficiency with Venous Stasis Ulcers: For CVI patients, the bar is higher. The patient must have one or more venous stasis ulcers that failed to heal after a six-month trial of conservative therapy directed by the treating physician. That trial must include a compression bandage system or garment, appropriate wound dressings, exercise, and limb elevation. Six months is a long time—make sure your documentation captures the start date of conservative therapy, not just the date the physician ordered the device.
Both indications require physician prescription and ongoing physician oversight. The CMS coverage policy is explicit on what "oversight" means: evaluation to determine medical necessity, instruction in device operation, a treatment plan specifying pressure settings and frequency/duration of use, and ongoing monitoring of the patient's response. Physicians who simply sign an order without this documented oversight chain put your DME claim at serious risk.
The medical necessity determination itself must include four specific elements per NCD 225:
| # | Covered Indication |
|---|---|
| 1 | The patient's diagnosis and prognosis |
| 2 | Symptoms and objective findings, including measurements that establish severity |
| 3 | The reason the device is required, including failed prior treatments |
| 4 | The clinical response to an initial treatment with the device—meaning changes in pre-treatment measurements, tolerance of the session, and the patient's or caregiver's ability to apply the device at home |
That fourth point trips up a lot of DME suppliers. The initial treatment response has to be documented before Medicare considers ongoing home use medically necessary. If you're submitting claims without that initial response documentation, you're billing blind.
There is no prior authorization requirement specified in this NCD, but that doesn't mean your MAC won't have local coverage determination (LCD) requirements layered on top. Check your jurisdiction's LCD for pneumatic compression devices before March 7, 2026.
CMS Pneumatic Compression Device Exclusions and Non-Covered Indications
The policy makes one specific coverage limitation explicit: HCPCS code E0652—the segmented, calibrated gradient pneumatic compression device—is only covered under specific circumstances. The policy document as provided is truncated at the exact point where CMS describes those circumstances, which is a documentation risk your billing team should flag now.
The practical implication: don't assume E0652 coverage defaults to the same rules as simpler PCD devices. If your team bills E0652, verify against the full NCD 225 text at CMS.gov and confirm your medical necessity documentation meets whatever the specific E0652 threshold is. If you're not certain how E0652's criteria apply to your patient mix, loop in your compliance officer before the March 7, 2026 effective date.
PCDs are also only covered in the home setting—not in facility settings where the DME benefit doesn't apply. A claim for inpatient or outpatient facility-based PCD use under this NCD will not be payable under these coverage rules.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Lymphedema (primary or secondary) | Covered | E0652 (specific device; see exclusions) | Requires 4-week conservative therapy trial: compression garment + exercise + elevation; physician must document no significant improvement |
| Chronic venous insufficiency with venous stasis ulcers | Covered | Not specified in this policy version | Requires 6-month conservative therapy trial; ulcer(s) must have failed to heal; lower extremities only |
| Chronic venous insufficiency without venous stasis ulcers | Not Covered | N/A | Policy explicitly limits CVI coverage to cases with venous stasis ulcers present |
| Segmented, calibrated gradient PCD (E0652) | Conditionally Covered | E0652 | Additional specific criteria apply per NCD 225; full criteria truncated in published summary—verify against full NCD text |
| PCD use in facility settings | Not Covered | N/A | Coverage limited to home setting under DME benefit |
CMS Pneumatic Compression Device Billing Guidelines and Action Items 2026
| # | Action Item |
|---|---|
| 1 | Pull every active PCD order and audit the conservative therapy documentation before March 7, 2026. For lymphedema patients, you need four weeks of conservative therapy documented with all three elements present. For CVI patients, you need six months. If any orders are missing that documentation, work with the referring physician now—not after a denial. |
| 2 | Confirm your initial treatment response documentation exists for every home PCD patient. CMS requires documented clinical response before approving ongoing home use. If you skipped this step because it wasn't clearly enforced previously, the modification to NCD 225 is your signal to fix that workflow across the board. |
| 3 | Identify every claim or order involving E0652 and flag it for additional review. The policy document references specific coverage limitations for E0652 that were truncated in the published summary. Pull the complete NCD 225 text directly from CMS.gov, confirm the E0652-specific criteria, and verify your documentation meets them. If you're billing E0652 regularly, brief your medical director on the coverage distinction. |
| 4 | Check your MAC's LCD for pneumatic compression devices. NCD 225 sets the floor, but your local coverage determination may add diagnosis code requirements, frequency limits, or documentation standards. Cross-reference both before March 7, 2026. |
| 5 | Update your physician order templates to capture all four medical necessity elements CMS requires. The policy lists them explicitly: diagnosis and prognosis, symptoms and objective findings with measurements, reason for device including failed prior treatments, and clinical response to initial treatment. A checklist built into your order form costs almost nothing and prevents the most common denial pattern on PCD claims. |
| 6 | Verify CVI orders specify lower extremity involvement and document venous stasis ulcers. CVI coverage is only for lower extremities, and only when venous stasis ulcers are present. Upper extremity CVI claims or CVI claims without documented ulcers will not meet Medicare medical necessity under this policy. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Pneumatic Compression Devices Under NCD 225
The policy data for NCD 225 does not publish a complete code list in the version captured here. The policy summary truncates before listing all applicable codes. One HCPCS code is referenced explicitly in the policy narrative:
HCPCS Codes Referenced in Policy Narrative
| Code | Type | Description | Notes |
|---|---|---|---|
| E0652 | HCPCS | Segmented, calibrated gradient pneumatic compression device | Covered only when specific additional criteria are met per NCD 225; criteria not fully published in this policy summary version |
A Note on Missing Codes
The absence of a full code list in the policy data is itself worth flagging. CMS NCDs typically reference a range of E-codes for pneumatic compression devices (various configurations of sleeves, pumps, and multi-chamber systems), but those codes are not confirmed in this version of NCD 225's published data.
Do not build your charge capture or LCD crosswalk assumptions on codes not listed here. Pull the complete NCD 225 from the CMS website directly, cross-reference with your MAC's LCD, and confirm the full applicable code set with your DME billing specialist before March 7, 2026. If you're unclear on how this maps to your specific device mix, your compliance officer or a DME-specialized billing consultant is the right resource—not an assumption.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.